Archive by author:
Howard FienbergReturn
Based in Washington, DC, Howard is the Insights Association's lobbyist for the marketing research and data analytics industry, focusing primarily on consumer privacy and data security, the Telephone Consumer Protection Act (TCPA), tort reform, and the funding and integrity of the decennial Census and the American Community Survey (ACS).
Howard has more than two decades of public policy experience. Before the Insights Association, he worked in Congress as senior legislative staffer for then-Representatives Christopher Cox (CA-48) and Cliff Stearns (FL-06). He also served more than four years with a science policy think tank, working to improve the understanding of scientific and social research and methodology among journalists and policymakers.
Howard is also co-director of The Census Project, a 900+ member coalition in support of a fair and accurate Census and ACS.
He has also served previously on the Board of Directors for the National Institute for Lobbying and Ethics and and the Association of Government Relations Professionals.
Howard has an MA International Relations from the University of Essex in England and a BA Honors Political Studies from Trent University in Canada, and has obtained the Certified Association Executive (CAE), Professional Lobbying Certificate (PLC) and the Public Policy Certificate (PPC).
When not running advocacy for the Insights Association, Howard enjoys hockey, NFL football, sci-fi and horror movies, playing with his dog, and spending time with family and friends.
MRA's cooperative lobbying efforts with the American Association of Political Consultants (AAPC) bore fruit this year in Alabama and Alaska.
Read More
The Commerce Manufacturing and Trade Subcommittee approved legislation yesterday that would strengthen the security of consumer data, while also making two important changes crucial to the conduct of marketing research in the United States.
Read More
Texas governor, Rick Perry, has signed a new health bill, H.B. 300, into law that enforces new obligations in addition to the requirements of the HIPAA privacy rule. The law, which becomes effective September 1, 2012, provides an expansive definition of a covered entity and is likely to include non-covered entities under HIPAA, including survey researchers.
Read More
On July 13, the House Appropriations Committee passed the Fiscal Year 2012 Commerce/Justice/Science Appropriations legislation, which had already cut about 25% from Census funding compared to FY11, without an amendment which would have further sliced away at the Census Bureau's budget.
Read More
Today, the House Appropriations Committee will consider amendments to the Fiscal Year 2012 Commerce/Justice/Science Appropriations legislation, which already cut about 25% from Census funding compared to FY11.
Read More
MRA testified this morning on legislation in the Vermont legislature, S. 104, which would legalize research with physicians.
Read More
The Alabama Senate passed S.B. 96, which would amend Section 17-5-16 of the Alabama Code to require “any communication via phone bank or other automated telephone dialing service to be conducted” with a “notice at the beginning and ending of the phone call that the communication was a paid political advertisement, clearly identifying the identification of the person, nonprofit corporation, entity, principal campaign committee, or political action committee that paid f...
Read More
Alaska Senate Majority Leader Kevin Meyer (R-O) introduced S.B. 40, and Rep. Scott Kawasaki (D-9) introduced H.B. 226, legislation which would forbid using “an automated telephone system, device, or facsimile machine for the selection and dialing of telephone numbers and playing of recorded messages if a message is completed to the dialed number for the purpose of: (A) offering goods or services for sale; (B) conveying information on goods or services in soliciting sales or purchases; (C) ...
Read More
MRA convinced a state legislator to exempt respondent incentives for marketing research from his legislation, which would have banned most payments from pharmaceutical and medical device manufacturers to health care professionals.
Read More
The Food and Drug Administration (FDA) has responded to MRA on our concerns regarding the confidentiality of marketing research data.
Read More